Comparing post-operative resource consumption following transcatheter aortic valve implantation (TAVI) and conventional aortic valve replacement in the UK
Authors:
- A. MathurAMA. Mathur
- L. BaldockLBL. Baldock
- S. OliverSOS. Oliver
- S. KennonSKS. Kennon
- 21 March 2014
- journal article
- Published by Informa Healthcare in Journal of Medical Economics
- Vol. 17 (5) , 357-364
Abstract
To define the in-hospital and 6-month post-discharge resource use, following Transcatheter Aortic Valve Implantation (TAVI) and conventional Aortic Valve Replacement (AVR) surgery within a single UK hospital. A local service evaluation of patients undergoing TAVI or AVR between January 2011 and May 2012 captured data until 6-months post-procedure, collected from hospital records and via a General Practitioner questionnaire. The main end-points were mortality, time in ITU/HDU, hospital length of stay (LoS), discharge destination, re-admission, and post-discharge primary/secondary care resource use. Sub-group analyses were performed for AVR patients aged ≥80 (AVR ≥ 80) and with EuroSCORE of ≥10 (AVR ES ≥ 10) to allow more direct comparison with 'TAVI type' patients. Results are given as means (standard deviation) for TAVI (n = 51), AVR (n = 188), AVR ≥ 80 (n = 48), and AVR ES ≥ 10 (n = 47), respectively, unless otherwise stated. Age in years was 83.0 (8.1), 71.2 (13.1), 84.1 (2.7), 79.4 (7.1); EuroSCORE was 24.7 (11.9), 8.1 (6.4), 12.0 (6.0), and 16.5 (6.6); post-operative LoS (days) was 11.5 (11.2), 10.9 (10.8), 14.3 (16.7), and 15.2 (17.7). For discharged patients, 0%, 7%, 13%, and 9% had unplanned cardiac-related re-admissions within 30-days of discharge. Time to first readmission was 74.6 (34.0), 35.0 (34.2), 20.8 (9.7), and 22.6 (14.3) days. This was a single-center retrospective evaluation, not prospectively powered to confirm differences in outcomes. Despite TAVI being performed in an older, higher risk population, LoS was similar to AVR. Most strikingly there were no cardiac-related re-admissions within 30-days for TAVI and time to first re-admission was significantly longer. This evaluation suggests that TAVI is clinically appropriate and provides economic advantages in both the hospital and post-discharge setting in this high risk group. Many patients undergoing TAVI are considered unfit for surgery and, hence, TAVI offers a treatment that delivers similar results to traditional AVR without the high risk associated with surgery.Keywords
This publication has 12 references indexed in Scilit:
- TCT-118 A Multidisciplinary, Multimodality, But Minimalist (3M) Approach To Transfemoral Transcatheter Aortic Valve Replacement Facilitates Safe Next Day Discharge In High Risk PatientsJACC, 2013
- Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluationHealth Technology Assessment, 2013
- The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative riskHeart, 2013
- A comprehensive review of the PARTNER trialThe Journal of Thoracic and Cardiovascular Surgery, 2013
- Long-term outcomes of isolated aortic valve replacement and concomitant AVR and coronary artery bypass graftingNetherlands Heart Journal, 2012
- Transcatheter aortic valve implantation versus surgical aortic valve replacement: A propensity score analysis in patients at high surgical riskThe Journal of Thoracic and Cardiovascular Surgery, 2012
- How best to handle the evidence in a cost-effectiveness analysis of TAVI in the UKTrials, 2011
- Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacementHeart, 2011
- Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registryHeart, 2011
- Aortic stenosisThe Lancet, 2009